• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[超声引导下细针穿刺活检在肝脏结节性病变诊断中的应用]

[The use of echo-guided fine-needle biopsy in the diagnosis of nodular hepatic lesions].

作者信息

Cioni G, Ferrari A, D'Alimonte P, Turrini F, Tincani E, Cristani A, Rebecchi A M, Bagni A, Di Marco G, Ventura E

机构信息

Cattedra e Divisione di Medicina Interna II, Università, Modena.

出版信息

Recenti Prog Med. 1996 Dec;87(12):586-8.

PMID:9102696
Abstract

211 patients were submitted to percutaneous ultrasound-guided liver biopsy: 184 patients (87.2%) had only one focal lesion, the other 27 had two or more lesions. In 9 patients (4.27%) the material drawn out from the liver was not adequate for microscopic examination (Retrieval Rate 95.7%). Histological evaluation revealed: absence of neoplasm in 67 patients (31.75%), benign lesion in 29 patients (13.74%), primitive malignant lesion in 70 patients (33.18%) and metastatic malignant lesion in 36 patients (17.06%). Combining the histological data with disease manifestation, biopsy showed a sensitivity of 95.1%, specificity of 100%, positive predictive value of 100%, negative predictive value of 89.4% and a diagnostic accuracy of 92.4%. None of the most important complications described in literature was observed. Our study confirms that ultrasound guided biopsy is a procedure of high diagnostic value in patients with nodular liver lesions, advantageous for its simplicity, low cost and safety.

摘要

211例患者接受了经皮超声引导下肝活检:184例患者(87.2%)仅有一个局灶性病变,另外27例有两个或更多病变。9例患者(4.27%)肝穿刺取材不适合显微镜检查(取材成功率95.7%)。组织学评估显示:67例患者(31.75%)无肿瘤,29例患者(13.74%)为良性病变,70例患者(33.18%)为原发性恶性病变,36例患者(17.06%)为转移性恶性病变。将组织学数据与疾病表现相结合,活检显示敏感性为95.1%,特异性为100%,阳性预测值为100%,阴性预测值为89.4%,诊断准确性为92.4%。未观察到文献中描述的任何重要并发症。我们的研究证实,超声引导下活检对肝脏结节性病变患者具有很高的诊断价值,因其操作简单、成本低且安全而具有优势。

相似文献

1
[The use of echo-guided fine-needle biopsy in the diagnosis of nodular hepatic lesions].[超声引导下细针穿刺活检在肝脏结节性病变诊断中的应用]
Recenti Prog Med. 1996 Dec;87(12):586-8.
2
Ultrasound-guided fine needle aspiration biopsy in differential diagnosis of portal vein tumor thrombosis.超声引导下细针穿刺活检在门静脉肿瘤血栓形成鉴别诊断中的应用
Hepatobiliary Pancreat Dis Int. 2005 May;4(2):234-8.
3
Endoscopic ultrasound-guided fine-needle aspiration biopsy of liver lesions: histological and cytological assessment.内镜超声引导下肝病变细针穿刺活检:组织学和细胞学评估
Endoscopy. 2003 Sep;35(9):743-9. doi: 10.1055/s-2003-41593.
4
[Ultrasound-guided thin-needle biopsy in focal liver diseases. I. Malignant hepatic tumors].[超声引导下肝脏局灶性病变细针穿刺活检。I. 肝脏恶性肿瘤]
Ultraschall Med. 1984 Dec;5(6):298-302. doi: 10.1055/s-2007-1012113.
5
Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre study.超声引导下细针穿刺活检早期肝细胞癌合并肝硬化:一项多中心研究。
Gut. 2004 Sep;53(9):1356-62. doi: 10.1136/gut.2003.032359.
6
Ultrasonically guided fine needle puncture of focal liver lesions. Review and personal experience.肝脏局灶性病变的超声引导下细针穿刺。综述及个人经验。
Acta Gastroenterol Belg. 1998 Apr-Jun;61(2):158-63.
7
Fine needle trucut biopsy of focal liver lesions: a new technique.肝脏局灶性病变的细针切割活检:一种新技术。
Dig Dis Sci. 1997 Oct;42(10):2077-81. doi: 10.1023/a:1018870501882.
8
[Ultrasound-guided thin-needle biopsy in focal liver diseases. II. Benign focal liver diseases].[超声引导下肝脏局灶性病变细针穿刺活检。II. 肝脏良性局灶性病变]
Ultraschall Med. 1984 Dec;5(6):303-11. doi: 10.1055/s-2007-1012114.
9
Is ultrasound-guided fine-needle biopsy effective for diagnosis of early HCC in liver cirrhosis?超声引导下细针穿刺活检对肝硬化早期肝癌的诊断是否有效?
Nat Clin Pract Gastroenterol Hepatol. 2005 Jan;2(1):16-7. doi: 10.1038/ncpgasthep0069.
10
[Portal thrombosis and liver cirrhosis. Value of ultrasound-guided puncture-biopsy of the thrombus].[门静脉血栓形成与肝硬化。超声引导下血栓穿刺活检的价值]
Gastroenterol Clin Biol. 1995 Jun-Jul;19(6-7):581-6.